Kelly A. Conway

7.4k total citations · 5 hit papers
18 papers, 6.0k citations indexed

About

Kelly A. Conway is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Kelly A. Conway has authored 18 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Neurology and 5 papers in Molecular Biology. Recurrent topics in Kelly A. Conway's work include Alzheimer's disease research and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Neurological disorders and treatments (5 papers). Kelly A. Conway is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Neurological disorders and treatments (5 papers). Kelly A. Conway collaborates with scholars based in United States. Kelly A. Conway's co-authors include Peter T. Lansbury, James D. Harper, Jean‐Christophe Rochet, Tomas T. Ding, Paul H. Weinreb, Robert M. Bieganski, Robin E. Williamson, Seung‐Jae Lee, Susan Lindquist and Hilal A. Lashuel and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Kelly A. Conway

16 papers receiving 5.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy

2000 1.3k citations Kelly A. Conway, Seung‐Jae Lee et al. Proceedings of the National Academy of Sciences profile →
Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

1998 1.3k citations Kelly A. Conway, James D. Harper et al. Nature Medicine profile →
NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded

1996 1.2k citations Paul H. Weinreb, Kelly A. Conway et al. Biochemistry profile →
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct

2001 921 citations Kelly A. Conway, Jean‐Christophe Rochet et al. Science profile →
Fibrils Formed in Vitro from α-Synuclein and Two Mutant Forms Linked to Parkinson's Disease are Typical Amyloid

2000 655 citations Kelly A. Conway, James D. Harper et al. Biochemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelly A. Conway United States	11	4.4k	2.7k	1.9k	1.8k	917	18	6.0k
Benjamin Dehay France	36	2.8k 0.6×	1.5k 0.6×	1.5k 0.8×	1.8k 1.0×	785 0.9×	90	5.2k
Laura A. Volpicelli‐Daley United States	42	4.3k 1.0×	2.0k 0.7×	2.1k 1.1×	2.3k 1.3×	1.2k 1.3×	71	6.9k
Anna Stieber United States	34	3.4k 0.8×	2.9k 1.1×	1.7k 0.9×	2.7k 1.5×	1.5k 1.7×	80	6.9k
Elisabeth Leroy United States	11	5.4k 1.2×	1.9k 0.7×	3.1k 1.6×	1.9k 1.1×	1.4k 1.5×	15	7.2k
Emma Deas United Kingdom	23	2.3k 0.5×	1.6k 0.6×	942 0.5×	2.1k 1.2×	546 0.6×	27	4.5k
Karin M. Danzer Germany	30	2.9k 0.7×	1.5k 0.6×	1.1k 0.6×	2.0k 1.1×	1.0k 1.1×	61	4.7k
Katerina E. Paleologou United Kingdom	22	2.3k 0.5×	1.5k 0.6×	928 0.5×	871 0.5×	445 0.5×	23	3.4k
Tim Bartels United States	19	2.4k 0.6×	1.5k 0.6×	1.0k 0.5×	1.2k 0.7×	608 0.7×	30	3.6k
Tomas T. Ding United States	10	1.9k 0.4×	1.4k 0.5×	820 0.4×	994 0.6×	409 0.4×	13	2.9k
Elisa Greggio Italy	41	3.7k 0.8×	1.4k 0.5×	1.2k 0.7×	2.4k 1.4×	1.0k 1.1×	89	5.2k

Countries citing papers authored by Kelly A. Conway

Since Specialization

Citations

This map shows the geographic impact of Kelly A. Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly A. Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly A. Conway more than expected).

Fields of papers citing papers by Kelly A. Conway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly A. Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly A. Conway. The network helps show where Kelly A. Conway may publish in the future.

Co-authorship network of co-authors of Kelly A. Conway

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly A. Conway. A scholar is included among the top collaborators of Kelly A. Conway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly A. Conway. Kelly A. Conway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Lin, Yin‐Guo, Brian P. Lieberman, Luis F. Gomez, et al.. (2022). Monoamine oxidase binding not expected to significantly affect [18F]flortaucipir PET interpretation. European Journal of Nuclear Medicine and Molecular Imaging. 49(11). 3797–3808. 8 indexed citations

Wright, Justin P., Yin‐Guo Lin, Jason Goodman, et al.. (2019). IC‐P‐165: STUDIES TO EVALUATE THE PUTATIVE BINDING OF THE TAU POSITRON EMISSION TOMOGRAPHY TRACER ¹⁸F‐AV‐1451 TO MONOAMINE OXIDASE‐B (MAO‐B). Alzheimer s & Dementia. 15(7S_Part_2).

Templin, Andrew T., Daniel T. Meier, Tami Wolden‐Hanson, et al.. (2018). Use of the PET ligand florbetapir for in vivo imaging of pancreatic islet amyloid deposits in hIAPP transgenic mice. Diabetologia. 61(10). 2215–2224. 8 indexed citations

Attardo, Giorgio, Kelly A. Conway, Jason Goodman, et al.. (2017). [O1–08–06]: AN UPDATE ON THE BINDING PROFILE OF FLORTAUCIPIR IN AD VERSUS NORMAL CNS PROTEINS AND NORMAL BRAIN. Alzheimer s & Dementia. 13(7S_Part_4). 1 indexed citations

Huang, Yifang, Chih Y. Ho, Charles H. Reynolds, et al.. (2010). Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads. Bioorganic & Medicinal Chemistry Letters. 20(10). 3158–3160. 21 indexed citations

Yohrling, George J., et al.. (2007). A Comparative Analysis of Brain and Plasma Aβ Levels in Eight Common Non-Transgenic Mouse Strains: Validation of a Specific Immunoassay for Total Rodent Aβ. Current Alzheimer Research. 4(3). 297–303. 8 indexed citations

Rochet, Jean‐Christophe, Tiago F. Outeiro, Kelly A. Conway, et al.. (2004). Interactions Among α-Synuclein, Dopamine, and Biomembranes: Some Clues for Understanding Neurodegeneration in Parkinson's Disease. Journal of Molecular Neuroscience. 23(1-2). 23–34. 149 indexed citations

Conway, Kelly A., Ellen W. Baxter, Kevin M. Felsenstein, & Allen B. Reitz. (2004). Emerging β-Amyloid Therapies for the Treatment of Alzheimer's Disease. 1(1). 361–384. 5 indexed citations

Conway, Kelly A., Ellen W. Baxter, Kevin M. Felsenstein, & Allen B. Reitz. (2003). Emerging β-Amyloid Therapies for the Treatment of Alzheimers Disease. Current Pharmaceutical Design. 9(6). 427–447. 34 indexed citations

10.

Darrow, Andrew L., Kelly A. Conway, Anil H. Vaidya, et al.. (2003). Virus-Based Expression Systems Facilitate Rapid Target In Vivo Functionality Validation and High-Throughput Screening. SLAS DISCOVERY. 8(1). 65–71. 8 indexed citations

11.

Parker, Michael H., Robert Chen, Kelly A. Conway, et al.. (2002). Synthesis of (−)-5,8-Dihydroxy-3R-methyl-2R-(dipropylamino)-1,2,3,4-tetrahydronaphthalene: An Inhibitor of β-Amyloid1–42 Aggregation. Bioorganic & Medicinal Chemistry. 10(11). 3565–3569. 19 indexed citations

12.

Conway, Kelly A., Jean‐Christophe Rochet, Robert M. Bieganski, & Peter T. Lansbury. (2001). Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct. Science. 294(5545). 1346–1349. 921 indexed citations breakdown →

13.

Conway, Kelly A., Jean‐Christophe Rochet, Tomas T. Ding, et al.. (2000). Accelerated Oligomerization by Parkinson's Disease Linked α‐Synuclein Mutants. Annals of the New York Academy of Sciences. 920(1). 42–45. 179 indexed citations

14.

Conway, Kelly A., Seung‐Jae Lee, Jean‐Christophe Rochet, et al.. (2000). Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proceedings of the National Academy of Sciences. 97(2). 571–576. 1269 indexed citations breakdown →

15.

Conway, Kelly A., James D. Harper, & Peter T. Lansbury. (2000). Fibrils Formed in Vitro from α-Synuclein and Two Mutant Forms Linked to Parkinson's Disease are Typical Amyloid. Biochemistry. 39(10). 2552–2563. 655 indexed citations breakdown →

16.

Rochet, Jean‐Christophe, Kelly A. Conway, & Peter T. Lansbury. (2000). Inhibition of Fibrillization and Accumulation of Prefibrillar Oligomers in Mixtures of Human and Mouse α-Synuclein. Biochemistry. 39(35). 10619–10626. 186 indexed citations

17.

Conway, Kelly A., James D. Harper, & Peter T. Lansbury. (1998). Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nature Medicine. 4(11). 1318–1320. 1257 indexed citations breakdown →

18.

Weinreb, Paul H., et al.. (1996). NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded. Biochemistry. 35(43). 13709–13715. 1241 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact